Market Place
Sourcing Support
All News #Library
APIs
Siegfried to acquire high-quality small molecules drug substance
26 Jan 2026 //
PRESS RELEASE
The Noramco Invests $25M into Halo Pharma Facility in NJ
19 Mar 2025 //
PRESS RELEASE
Diversifying the Supply of Raw Materials
12 Jun 2024 //
PRESS RELEASE
Noramco Aligns with Purisys and Halo Pharma to Create Noramco Group
15 Mar 2024 //
PRESS RELEASE
Noramco Announces Submission of the DMF Methylnaltrexone
01 Nov 2022 //
PRESS RELEASE
Noramco Announces Submission of DMF for Lisdexamfetamine Dimesylate
03 Dec 2021 //
PRESS RELEASE
RespireRx Pharmaceuticals Inc. Announces Appointment of Tim Jones to its Board of Directors
03 Feb 2020 //
GLOBENEWSWIRE
API MFG Beware – New Washington Opioid Lawsuit Targets J&J’s API Business
20 Jan 2020 //
POLICYMED
Noramco and AFC strike deal for controlled substance APIs
22 Mar 2018 //
FIERCE PHARMA
Noramco signs AMPAC to top up API and intermediates supply
21 Mar 2018 //
IN-PHARMATECHNOLOGIST
Noramco planning formulation tech unit alongside opioid API business
07 Mar 2017 //
IN PHARMATECHNOLOGIST
Copyright © 2026 LePro PharmaCompass OPC Private Limited, All rights reserved.